Monopar Therapeutics (MNPR) Enterprise Value Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -96.21% |
| Sep 30, 2025 | -109.31% |
| Jun 30, 2025 | -33.87% |
| Mar 31, 2025 | -30.62% |
| Dec 31, 2024 | -31.79% |
| Sep 30, 2024 | 35.41% |
| Jun 30, 2024 | 36.45% |
| Mar 31, 2024 | 32.80% |
| Dec 31, 2023 | 24.28% |
| Sep 30, 2023 | 32.56% |
| Jun 30, 2023 | 16.84% |
| Mar 31, 2023 | 23.10% |
| Dec 31, 2022 | 14.75% |
| Sep 30, 2022 | -45.78% |
| Jun 30, 2022 | -47.51% |
| Mar 31, 2022 | -44.70% |
| Dec 31, 2021 | -42.66% |
| Sep 30, 2021 | -43.14% |
| Jun 30, 2021 | -42.62% |
| Mar 31, 2021 | -42.06% |
| Dec 31, 2020 | -23.06% |
| Sep 30, 2020 | -19.31% |
| Jun 30, 2020 | -43.10% |
| Mar 31, 2020 | -52.49% |
| Dec 31, 2019 | -66.30% |